Experiment: 2JNF

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.7 mM [U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
2	2D 1H-13C HSQC	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
3	3D 1H-15N NOESY	0.7 mM [U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
4	3D 1H-13C NOESY	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
5	3D HN(COCA)CB	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
6	3D HNCA	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
7	3D HNCACB	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
8	3D CBCA(CO)NH	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
9	3D HNCO	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
10	3D 1H-15N TOCSY	0.7 mM [U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298
11	3D HCCH-TOCSY	0.7 mM [U-99% 13C; U-99% 15N] muscle protein, 90% H2O, 10% D2O	90% H2O/10% D2O	100 mM NaCl	6.8	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY	500
2	Varian	INOVA	600
3	Varian	INOVA	800
4	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics	water refinement	VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	20
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR		Varian
2	collection	XwinNMR		Bruker Biospin
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	structure solution	ARIA	1.2	Linge, O'Donoghue and Nilges
5	data analysis	XEASY		Bartels et al.
6	refinement	ARIA	1.2	Linge, O'Donoghue and Nilges

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.